Find Mirodenafil manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 862189-95-5, Mirodenafil [inn], Sk3530, Sk-3530, Sk3530 free base, Sk-3530 free base
Molecular Formula
C26H37N5O5S
Molecular Weight
531.7  g/mol
InChI Key
MIJFNYMSCFYZNY-UHFFFAOYSA-N
FDA UNII
504G362H0H

Mirodenafil
Mirodenafil has been used in trials studying the treatment and supportive care of Kidney Diseases, Urologic Diseases, Renal Insufficiency, Erectile Dysfunction, and Male Erectile Dysfunction.
1 2D Structure

Mirodenafil

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
5-ethyl-2-[5-[4-(2-hydroxyethyl)piperazin-1-yl]sulfonyl-2-propoxyphenyl]-7-propyl-3H-pyrrolo[3,2-d]pyrimidin-4-one
2.1.2 InChI
InChI=1S/C26H37N5O5S/c1-4-7-19-18-30(6-3)24-23(19)27-25(28-26(24)33)21-17-20(8-9-22(21)36-16-5-2)37(34,35)31-12-10-29(11-13-31)14-15-32/h8-9,17-18,32H,4-7,10-16H2,1-3H3,(H,27,28,33)
2.1.3 InChI Key
MIJFNYMSCFYZNY-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCCC1=CN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CCO)OCCC)CC
2.2 Other Identifiers
2.2.1 UNII
504G362H0H
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 5-ethyl-2-(5-(4-(2-hydroxyethyl)piperazine-1-sulfonyl)-2-propoxyphenyl)-7-propyl-3,5-dihydro-4h-pyrrolo(3,2-d)pyrimidin-4-one

2.3.2 Depositor-Supplied Synonyms

1. 862189-95-5

2. Mirodenafil [inn]

3. Sk3530

4. Sk-3530

5. Sk3530 Free Base

6. Sk-3530 Free Base

7. Mvix

8. 504g362h0h

9. 5-ethyl-2-[5-[4-(2-hydroxyethyl)piperazin-1-yl]sulfonyl-2-propoxyphenyl]-7-propyl-1h-pyrrolo[3,2-d]pyrimidin-4-one

10. 5-ethyl-2-[5-[4-(2-hydroxyethyl)piperazin-1-yl]sulfonyl-2-propoxyphenyl]-7-propyl-3h-pyrrolo[3,2-d]pyrimidin-4-one

11. Mirodenafilo

12. Mirodenafilum

13. Unii-504g362h0h

14. 5-ethyl-2-(5-((4-(2-hydroxyethyl)piperazin-1-yl)sulfonyl)-2-propoxyphenyl)-7-propyl-3,5-dihydro-4h-pyrrolo(3,2-d)pyrimidin-4-one

15. 5-ethyl-2-(5-{[4-(2-hydroxyethyl)piperazin-1-yl]sulfonyl}-2-propoxyphenyl)-7-propyl-3,5-dihydro-4h-pyrrolo[3,2-d]pyrimidin-4-one

16. 862189-96-6

17. Mirodenafil [inci]

18. Mirodenafil [who-dd]

19. Schembl3845775

20. Chembl4297518

21. Schembl15481149

22. Gtpl11738

23. Dtxsid50881265

24. Chebi:136049

25. Bcp07740

26. Ex-a5487

27. Sk3530sk3530

28. Zinc35077050

29. Db11792

30. Ncgc00378703-02

31. Hy-14930

32. Ft-0672413

33. Ft-0699556

34. 189m955

35. A914996

36. Q6873840

37. 5-ethyl-2-(5-(4-(2-hydroxyethyl)piperazine-1-sulfonyl)-2-propoxyphenyl)-7-propyl-3,5-dihydro-4h-pyrrolo(3,2-d)pyrimidin-4-one

38. 5-ethyl-2-{5-[4-(2-hydroxyethyl)piperazin-1-ylsulfonyl]-2-n-propoxyphenyl}-7-n-propyl-3,5-dihydro-4h-pyrrolo[3,2-d]pyrimidin-4-one

2.4 Create Date
2019-01-15
3 Chemical and Physical Properties
Molecular Weight 531.7 g/mol
Molecular Formula C26H37N5O5S
XLogP32.2
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count8
Rotatable Bond Count11
Exact Mass531.25154047 g/mol
Monoisotopic Mass531.25154047 g/mol
Topological Polar Surface Area125 Ų
Heavy Atom Count37
Formal Charge0
Complexity902
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Phosphodiesterase 5 Inhibitors

Compounds that specifically inhibit PHOSPHODIESTERASE 5. (See all compounds classified as Phosphodiesterase 5 Inhibitors.)


KDMF

read-more
read-more

01

Estechpharma

South Korea
Medlab Asia & Asia Health
Not Confirmed
arrow

Estechpharma

South Korea
arrow
Medlab Asia & Asia Health
Not Confirmed

Mirodenafil

Registrant Name : Polaris AI Pharma Co., Ltd.

Registration Date : 2021-02-09

Registration Number : 1962-7-ND

Manufacturer Name : Estech Pharma Co., Ltd.

Manufacturer Address : 25 Balan Industrial Complex-ro, Hyangnam-eup, Hwaseong-si, Gyeonggi-do, 34 Block 10-1...

blank

02

Pharmacostech

South Korea
Medlab Asia & Asia Health
Not Confirmed
arrow

Pharmacostech

South Korea
arrow
Medlab Asia & Asia Health
Not Confirmed

Mirodenafil

Registrant Name : Pharmacostec Co., Ltd.

Registration Date : 2015-08-24

Registration Number : 2572-2-ND

Manufacturer Name : Pharmacostech Co., Ltd. @ [S...

Manufacturer Address : 47, Yakjedanji-ro, Hyangnam-eup, Hwaseong-si, Gyeonggi-do @ 325, Expo-ro, Yuseong-gu,...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty